---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-317728"
form_type: "8-K"
ticker: "ITRMF"
cik: "0001659323"
company_name: "Iterum Therapeutics plc"
filed_at: "2025-12-12T23:59:59+00:00"
generated_at: "2026-05-16T13:21:47.593273+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Iterum Therapeutics receives Nasdaq delisting notice for MVLS below $35M

## Summary
- Nasdaq notified Iterum on Dec 11, 2025 that MVLS <$35M for 30 consecutive business days; given 180 days until June 9, 2026 to regain compliance.
- Company also remains out of compliance with $1.00 minimum bid price rule since August 2025, with compliance period ending Feb 23, 2026.
- Failure to cure either deficiency could lead to delisting; company may appeal but no assurance of success.
- Notice has no immediate effect on listing; common stock continues trading on Nasdaq.

## SEC filing metadata
- accession: 0001193125-25-317728
- form_type: 8-K
- ticker: ITRMF
- cik: 0001659323
- company_name: Iterum Therapeutics plc
- filed_at: 2025-12-12T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1659323/000119312525317728/0001193125-25-317728-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1659323/000119312525317728/itrm-20251211.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-317728
- JSON: https://secwatch.observer/filing/0001193125-25-317728.json
- Plain text: https://secwatch.observer/filing/0001193125-25-317728.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.